13. IP Asint Pro-BNP (pg/ml) DOSAGGIO DI pro-BNP in 17 sieri di soggetti con IP e 77 asintomatici Cut-off 145 Eur Heart J Supp 2004; 6: F35-F39.
14. INFEZIONE DA HIV ED IPERTENSIONE ARTERIOSA POLMONARE 45 pazienti con infezione da HIV ed IP, afferenti a Pavia dal dicembre 1997 all’ ottobre 2010 alla Clinica Malattie Infettive ed alla Divisione Malattie Infettive e Tropicali Policlinico San Matteo, Pavia
17. Curve di sopravvivenza PAH - HIV Opravil M, et al. Am J Respir Crit Care Med. 1997;155:990-995 Anni Sopravvivenza Pazienti con infezione HIV con PAH (n=19) Pazienti con infezione HIV senza PAH (n=19) p < 0.05 0 2 1 3 4 9 5 6 7 8 0.0 0.2 0.4 0.6 0.8 1.0
18.
19.
20.
21.
22.
23.
24.
25.
Editor's Notes
Dire solo che dati preliminari fanno pensare che il test sia dotato di:
PPH is an independent risk factor for mortality in patients with HIV infection. The survival probability of patients with PPH associated HIV has been shown to be half that of HIV patients without PPH. The median survival was 1.3 vs. 2.6 years ( p < 0.05). 1 In a review of 131 cases of PAH associated with HIV identified from the literature, the median time from diagnosis to death was 6 months. 2 Two-thirds of the deaths were due to the consequences of PH, including right-sided heart failure, cardiogenic shock, and sudden death. 1 Opravil M, Pecheree M, Speich R, Joller-Jemelka HI, Jenni R, Russi EW, et al. HIV-associated primary pulmonary hypertension. A case control study. Am J Respir Crit Care Med . 1997;155:990-995. 2 Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA. HIV-related pulmonary hypertension. Analytic review of 131 cases. Chest . 2000. 181:1133-1141.